查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1474902

多组体学市场规模、份额和趋势分析报告：按产品/服务、按类型、按平台、按应用、按最终用途、按地区和细分市场预测，2024-2030 年

Multiomics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables), By Type (Single-cell, Bulk), By Platform, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

多组体学市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球多组体学市场规模将达到63.8亿美元，2024年至2030年复合年增长率为15.29%。

体学技术成本下降以及私人和公共机构投资和资金筹措增加等因素预计将推动市场发展。由于製药公司、生技公司和学术研究机构的需求不断增加，市场竞争日益激烈，预计也将在预测期内推动市场成长。

随着技术的进步，体学技术的成本预计会降低，使研究人员更容易获得资料集，从而推动市场成长。公司正在专注于技术进步以降低成本。例如，Amazon Web Services 于 2022 年 11 月宣布推出 Amazon Omics 服务。该服务利用生物资讯学友善的储存选项来储存原始序列资料并降低成本。因此，较低的成本预计将使研究人员和临床医生更容易获得体学技术。这种成本的降低预计将增加多组体学方法的采用。

私人和公共参与者的投资和资金的增加预计将增加对多组体学产品和服务的需求。多家公司正大力投资多组体学平台和技术的开发。例如，2022年1月，罗氏向生技公司Freenome投资2.9亿美元。该投资用于加速该公司用于早期癌症检测的多组体学平台。此外，2023 年 5 月，MultiOmic Health 完成了 620 万美元的资金筹措，用于建立精准治疗药物发现平台。因此，由于资金筹措和投资的增加，市场预计将看到各种新平台和产品的开发。

市场相关人员日益关注开发创新产品和服务也是推动市场需求成长的关键因素。为了应对日益激烈的竞争，各公司正在开发新颖的平台。例如，2023 年 2 月，Via Scientific, Inc. 宣布推出 Foundry，这是一个多体学加速器平台，支援多组体学研究期间复杂资料和分析任务的自动化。预计此类产品的推出将在预测期内推动该行业的发展。

多组体学市场报告亮点

  • 按产品/服务划分，产品部门在市场中占据主导地位，2023年销售份额将达到60.5%，这是由于设备和软体等产品的推出不断增加。
  • 按类型划分，批量多组体学是业界最大的收益贡献者。另一方面，由于对单细胞多组体学理解复杂生物系统的需求不断增加，预计单细胞多组体学在预测期内将以 17.8% 的复合年增长率增长最快。
  • 以平台来看，基因组学在市场上占据主导地位，2023 年销售份额将达到 40.6%。这种增长是由于该细分市场提供了大量产品。
  • 从应用来看，细胞生物学领域到2023年将占据38.8%的份额，占据全球产业主导地位。相反，预计肿瘤学领域在预测期内将达到最高成长率。
  • 按最终用途划分，学术和研究机构部门是业界最大的收益贡献者，份额为 50.7%。相较之下，由于对多组体学加速药物发现和开发的需求不断增加，製药和生物技术公司预计将成长最快。
  • 由于该地区存在主要市场参与者，北美在 2023 年以 48.68% 的收益占有率主导全球产业。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第 4 章 多组体学市场：产品与服务的商业分析

  • 细分仪表板
  • 全球多组体学市场：产品与服务波动分析
  • 2018-2030 年全球多组体学市场规模和趋势分析（按产品和服务）
  • 产品
  • 服务

第五章 多组体学市场：类型的商业分析

  • 细分仪表板
  • 全球多组体学市场：类型变异分析
  • 2018-2030 年全球多组体学市场规模与趋势分析（按类型）
  • 单细胞多组体学
  • 批量多组体学

第六章 多组体学市场：平台业务分析

  • 细分仪表板
  • 全球多组体学市场：平台波动分析
  • 2018-2030 年全球多组体学市场规模与趋势分析（按平台）
  • 基因组学
  • 转录组学
  • 蛋白质体学
  • 代谢体学
  • 综合体学平台

第 7 章 多组体学市场：应用程式的商业分析

  • 细分仪表板
  • 全球多组体学市场：应用变迁分析
  • 2018-2030 年全球多组体学市场规模与趋势分析（按应用）
  • 细胞生物学
  • 肿瘤学
  • 神经病学
  • 免疫学

第 8 章 多组体学市场：最终用途业务分析

  • 细分仪表板
  • 全球多组体学市场：最终用途变异分析
  • 2018-2030 年全球多组体学市场规模与趋势分析（依最终用途）
  • 学术/研究机构
  • 製药和生物技术公司
  • 其他的

第 9 章 多组体学市场：区域估计与趋势分析

  • 区域仪表板
  • 2018-2030 年市场规模与预测/趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争格局

  • 参与企业
  • 策略规划
  • 2023 年企业市场分析
  • 参与企业概况
    • BD
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc
    • Danaher
    • PerkinElmer Inc.
    • Shimadzu Corporation
    • Bruker
    • QIAGEN
    • Agilent Technologies, Inc.
    • BGI
Product Code: GVR-4-68040-136-5

Multiomics Market Growth & Trends:

The global multiomics market size is expected to reach USD 6.38 billion by 2030, registering a CAGR of 15.29% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the decreasing costs of omics technologies and growing investment and funding from private and public players are expected to drive the market. In addition, rising competition in the market owing to increasing demand from pharmaceutical & biotechnology companies and academic research institutions is also anticipated to propel the market growth over the forecast period.

With the improvement in technologies, the cost of omics technologies is anticipated to reduce, which can increase the accessibility of datasets to researchers, consequently driving market growth. Companies are focusing on technological advancements to lower costs. For instance, in November 2022, Amazon Web Services introduced an Amazon Omics service. This service utilizes bioinformatics-aware storage options to store raw sequence data and to decrease costs. Thus, the decreasing costs are anticipated to increase the accessibility of omics technologies to researchers and clinicians. Such cost reduction is expected to increase the adoption of multiomics approaches.

The growing investments and funding from private and public participants are anticipated to boost the demand for multi-omics products and services. Various companies are significantly investing in the development of multiomics platforms and technologies. For instance, in January 2022, Roche invested USD 290 million in Freenome, a biotech company. This investment was used to accelerate multiomics platforms for early cancer detection. In addition, in May 2023, MultiOmic Health completed a funding round of USD 6.2 million to construct a precision therapeutics discovery platform. Thus, the rising funding and investments are expected to develop various novel platforms and products in the markets

The rising emphasis of market players to develop innovative products and services is another vital factor propelling market demand forward. Various companies are developing novel platforms to sustain the rising competition. For instance, in February 2023, Via Scientific, Inc. introduced a multi-omics accelerator platform, Foundry, that supports the automation of complex data and analytical work during multi-omics research. Such product launches are anticipated to drive the industry over the forecast period.

Multiomics Market Report Highlights:

  • Based on product & service, the product segment dominated the market with a revenue share of 60.5% in 2023, which can be attributed to the rising launches of products such as instruments and software
  • Based on type, the bulk multiomics held the largest revenue contributor for the industry. In contrast, single-cell multi-omics is expected to grow at the fastest CAGR of 17.8% over the forecast period, due to increasing demand for single-cell multi-omics to comprehend complex biology systems
  • Based on platform, genomics dominated the market with a revenue share of 40.6% in 2023. The growth is attributed to the high number of products available in this segment
  • Based on application, the cell biology segment dominated the global industry with a share of 38.8% in 2023. In contrast, the oncology segment is projected to register the highest growth rate during the projected period
  • Based on end-use, the academic and research institute segment was the largest revenue contributor for the industry, with a share of 50.7%. In contrast, pharmaceutical and biotechnology companies are expected to witness the fastest growth owing to increasing demand for multi-omics to accelerate drug discovery and development
  • North America dominated the global industry in 2023 with a revenue share of 48.68%, owing to the presence of key market players in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Type
    • 1.2.3. Platform
    • 1.2.4. Application
    • 1.2.5. End-use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. The increasing interest of researchers in the field of single-cell genomics
      • 3.2.1.2. Rising incidence of chronic diseases
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High initial costs
      • 3.2.2.2. Stringent government policies and regulations
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Market: Product & Service Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Multiomics Market Product & Service Movement Analysis
  • 4.3. Global Multiomics Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Product
    • 4.4.1. Global Product Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Instruments
      • 4.4.2.1. Global Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Consumables
      • 4.4.3.1. Global Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Software
      • 4.4.4.1. Global Software Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Multiomics Market: Type Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Multiomics Market Type Movement Analysis
  • 5.3. Global Multiomics Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Single-cell Multiomics
    • 5.4.1. Global Single-cell Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Bulk Multiomics
    • 5.5.1. Global Bulk Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Multiomics Market: Platform Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Multiomics Market Platform Movement Analysis
  • 6.3. Global Multiomics Market Size & Trend Analysis, by Platform, 2018 to 2030 (USD Million)
  • 6.4. Genomics
    • 6.4.1. Global Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Transcriptomics
    • 6.5.1. Global Transcriptomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Proteomics
    • 6.6.1. Global Proteomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Metabolomics
    • 6.7.1. Global Metabolomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Integrated Omics Platforms
    • 6.8.1. Global Integrated Omics Platforms Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Multiomics Market: Application Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Multiomics Market Application Movement Analysis
  • 7.3. Global Multiomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Cell Biology
    • 7.4.1. Global Cell Biology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Neurology
    • 7.6.1. Global Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Immunology
    • 7.7.1. Global Immunology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Multiomics Market: End-use Business Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Multiomics Market End-use Movement Analysis
  • 8.3. Global Multiomics Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 8.4. Academic & Research Institutes
    • 8.4.1. Global Academic and Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Pharmaceutical & Biotechnology Companies
    • 8.5.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Multiomics Market: Regional Estimates & Trend Analysis by Product & Service, Type, Platform, Application, & End-use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 9.3. North America
    • 9.3.1. North America Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Australia Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. Thailand Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. South Korea Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.3. Mexico
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Mexico Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.4. Argentina
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. Argentina Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait Multiomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Participant Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2023
  • 10.4. Participant's Overview
    • 10.4.1. BD
      • 10.4.1.1. Overview
      • 10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Thermo Fisher Scientific Inc.
      • 10.4.2.1. Overview
      • 10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Illumina, Inc
      • 10.4.3.1. Overview
      • 10.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Danaher
      • 10.4.4.1. Overview
      • 10.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. PerkinElmer Inc.
      • 10.4.5.1. Overview
      • 10.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Shimadzu Corporation
      • 10.4.6.1. Overview
      • 10.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Bruker
      • 10.4.7.1. Overview
      • 10.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. QIAGEN
      • 10.4.8.1. Overview
      • 10.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Agilent Technologies, Inc.
      • 10.4.9.1. Overview
      • 10.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. BGI
      • 10.4.10.1. Overview
      • 10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 6 Global multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 Global multiomics market, by region, 2018 - 2030 (USD Million)
  • Table 9 North America multiomics market, by country, 2018 - 2030 (USD Million)
  • Table 10 North America multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 11 North America multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 12 North America multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 13 North America multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 14 North America multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 U.S. multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 16 U.S. multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 17 U.S. multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 18 U.S. multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 19 U.S. multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Canada multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 21 Canada multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 22 Canada multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 23 Canada multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Canada multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Europe multiomics market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 27 Europe multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 28 Europe multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 29 Europe multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Europe multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 UK multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 32 UK multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 33 UK multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 34 UK multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 35 UK multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Germany multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 37 Germany multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 38 Germany multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 39 Germany multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 40 Germany multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 France multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 42 France multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 43 France multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 44 France multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 45 France multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Italy multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 47 Italy multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 48 Italy multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 49 Italy multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 50 Italy multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Spain multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 52 Spain multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 53 Spain multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 54 Spain multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 55 Spain multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Denmark multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 57 Denmark multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 58 Denmark multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 59 Denmark multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 60 Denmark multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Sweden multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 62 Sweden multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 63 Sweden multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 64 Sweden multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Sweden multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Norway multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 67 Norway multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 68 Norway multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 69 Norway multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 70 Norway multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific multiomics market, by country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Japan multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 78 Japan multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 79 Japan multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 80 Japan multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Japan multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 China multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 83 China multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 84 China multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 85 China multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 86 China multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 India multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 88 India multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 89 India multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 90 India multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 91 India multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Australia multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 93 Australia multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 94 Australia multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 95 Australia multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 96 Australia multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 97 Thailand multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 98 Thailand multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 99 Thailand multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 100 Thailand multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 101 Thailand multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 102 South Korea multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 103 South Korea multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 104 South Korea multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 105 South Korea multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 106 South Korea multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 Latin America multiomics market, by country, 2018 - 2030 (USD Million)
  • Table 108 Latin America multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 109 Latin America multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 110 Latin America multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 111 Latin America multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 112 Latin America multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 113 Brazil multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 114 Brazil multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 115 Brazil multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 116 Brazil multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 117 Brazil multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 118 Mexico multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 119 Mexico multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 120 Mexico multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 121 Mexico multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 122 Mexico multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 123 Argentina multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 124 Argentina multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 125 Argentina multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 126 Argentina multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 127 Argentina multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa multiomics market, by country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 134 South Africa multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 135 South Africa multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 136 South Africa multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 137 South Africa multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 138 South Africa multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 144 UAE multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 145 UAE multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 146 UAE multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 147 UAE multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 148 UAE multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait multiomics market, by product & service, 2018 - 2030 (USD Million)
  • Table 150 Kuwait multiomics market, by type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait multiomics market, by platform, 2018 - 2030 (USD Million)
  • Table 152 Kuwait multiomics market, by application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait multiomics market, by end-use, 2018 - 2030 (USD Million)
  • Table 154 Participant's overview
  • Table 155 Financial performance
  • Table 156 Key companies undergoing expansions
  • Table 157 Key companies undergoing acquisitions
  • Table 158 Key companies undergoing collaborations
  • Table 159 Key companies launching new products
  • Table 160 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Multiomics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Multiomics market driver analysis
  • Fig. 14 Multiomics market restraint analysis
  • Fig. 15 Multiomics market: Porter's analysis
  • Fig. 16 Multiomics market: PESTEL analysis
  • Fig. 17 Multiomics market: Product & service outlook and key takeaways
  • Fig. 18 Multiomics market: Product & service market share analysis, 2023 - 2030
  • Fig. 19 Global multiomics by products market, 2018 - 2030 (USD Million)
  • Fig. 20 Global multiomics by instruments market, 2018 - 2030 (USD Million)
  • Fig. 21 Global multiomics by consumables market, 2018 - 2030 (USD Million)
  • Fig. 22 Global multiomics by software market, 2018 - 2030 (USD Million)
  • Fig. 23 Global multiomics by services market, 2018 - 2030 (USD Million)
  • Fig. 24 Multiomics market: Type outlook and key takeaways
  • Fig. 25 Multiomics market: Type market share analysis, 2023 - 2030
  • Fig. 26 Global single-cell multiomics by men market, 2018 - 2030 (USD Million)
  • Fig. 27 Global multiomics by bulk multiomics market, 2018 - 2030 (USD Million)
  • Fig. 28 Multiomics market: Platform outlook and key takeaways
  • Fig. 29 Multiomics market: Platform market share analysis, 2023 - 2030
  • Fig. 30 Global multiomics by genomics market, 2018 - 2030 (USD Million)
  • Fig. 31 Global multiomics by transcriptomics market, 2018 - 2030 (USD Million)
  • Fig. 32 Global multiomics by proteomics market, 2018 - 2030 (USD Million)
  • Fig. 33 Global multiomics by metabolomics market, 2018 - 2030 (USD Million)
  • Fig. 34 Global multiomics by integrated omics platforms market, 2018 - 2030 (USD Million)
  • Fig. 35 Multiomics market: Application outlook and key takeaways
  • Fig. 36 Multiomics market: Application market share analysis, 2023 - 2030
  • Fig. 37 Global multiomics by cell biology market, 2018 - 2030 (USD Million)
  • Fig. 38 Global multiomics by oncology market, 2018 - 2030 (USD Million)
  • Fig. 39 Global multiomics by neurology market, 2018 - 2030 (USD Million)
  • Fig. 40 Global multiomics by immunology market, 2018 - 2030 (USD Million)
  • Fig. 41 Multiomics market: End-use outlook and key takeaways
  • Fig. 42 Multiomics market: End-use market share analysis, 2023 - 2030
  • Fig. 43 Global multiomics by academic and research institutes market, 2018 - 2030 (USD Million)
  • Fig. 44 Global multiomics by pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 45 Global multiomics by others market, 2018 - 2030 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. key country dynamics
  • Fig. 49 U.S. multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Canada key country dynamics
  • Fig. 51 Canada multiomics market, 2018 - 2030 (USD Million)
  • Fig. 52 Europe multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 UK key country dynamics
  • Fig. 54 UK multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Germany key country dynamics
  • Fig. 56 Germany multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 France key country dynamics
  • Fig. 58 France multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Italy key country dynamics
  • Fig. 60 Italy multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Spain key country dynamics
  • Fig. 62 Spain multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Denmark key country dynamics
  • Fig. 64 Denmark multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Sweden key country dynamics
  • Fig. 66 Sweden multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Norway key country dynamics
  • Fig. 68 Norway multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Asia-Pacific multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Japan key country dynamics
  • Fig. 71 Japan multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 China key country dynamics
  • Fig. 73 China multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 India key country dynamics
  • Fig. 75 India multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Australia key country dynamics
  • Fig. 77 Australia multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand key country dynamics
  • Fig. 79 Thailand multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea key country dynamics
  • Fig. 81 South Korea multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil key country dynamics
  • Fig. 84 Brazil multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Mexico key country dynamics
  • Fig. 86 Mexico multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina key country dynamics
  • Fig. 88 Argentina multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 MEA multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 South Africa key country dynamics
  • Fig. 91 South Africa multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Saudi Arabia key country dynamics
  • Fig. 93 Saudi Arabia multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 UAE key country dynamics
  • Fig. 95 UAE multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait key country dynamics
  • Fig. 97 Kuwait multiomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Key company categorization
  • Fig. 99 Company market positioning
  • Fig. 100 Market participant categorization
  • Fig. 101 Strategy framework